tetano
Editor, Senior Moderator
Cureus
. 2022 Mar 20;14(3):e23333.
doi: 10.7759/cureus.23333. eCollection 2022 Mar.
Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review
Haider Ghazanfar[SUP] 1 [/SUP], Sameer Kandhi[SUP] 1 [/SUP], Dongmin Shin[SUP] 1 [/SUP], Aruna Muthumanickam[SUP] 1 [/SUP], Hitesh Gurjar[SUP] 1 [/SUP], Zaheer A Qureshi[SUP] 2 1 3 [/SUP], Mohammed Shaban[SUP] 1 [/SUP], Mohamed Farag[SUP] 4 [/SUP], Asim Haider[SUP] 4 [/SUP], Pravash Budhathoki[SUP] 4 [/SUP], Tanushree Bhatt[SUP] 1 [/SUP], Ali Ghazanfar[SUP] 5 [/SUP], Abhilasha Jyala[SUP] 1 [/SUP], Harish Patel[SUP] 6 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world, causing a pandemic that has resulted in more than 5 million deaths globally. The gastrointestinal (GI) tract is known to have high expression of angiotensin-converting enzyme 2 (ACE2) receptors in the human body, making it prone to direct damage from the cellular invasion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous GI symptoms have been reported among patients with COVID-19. This systemic review details the mechanism and effects of COVID-19 on the GI tract along with the hepatobiliary and pancreatic systems.
Keywords: angiotensin converting enzyme 2; covid-19; gastrointestinal tract; liver; pancreas.
. 2022 Mar 20;14(3):e23333.
doi: 10.7759/cureus.23333. eCollection 2022 Mar.
Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review
Haider Ghazanfar[SUP] 1 [/SUP], Sameer Kandhi[SUP] 1 [/SUP], Dongmin Shin[SUP] 1 [/SUP], Aruna Muthumanickam[SUP] 1 [/SUP], Hitesh Gurjar[SUP] 1 [/SUP], Zaheer A Qureshi[SUP] 2 1 3 [/SUP], Mohammed Shaban[SUP] 1 [/SUP], Mohamed Farag[SUP] 4 [/SUP], Asim Haider[SUP] 4 [/SUP], Pravash Budhathoki[SUP] 4 [/SUP], Tanushree Bhatt[SUP] 1 [/SUP], Ali Ghazanfar[SUP] 5 [/SUP], Abhilasha Jyala[SUP] 1 [/SUP], Harish Patel[SUP] 6 [/SUP]
Affiliations
- PMID: 35464519
- PMCID: PMC9017282
- DOI: 10.7759/cureus.23333
Abstract
Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world, causing a pandemic that has resulted in more than 5 million deaths globally. The gastrointestinal (GI) tract is known to have high expression of angiotensin-converting enzyme 2 (ACE2) receptors in the human body, making it prone to direct damage from the cellular invasion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous GI symptoms have been reported among patients with COVID-19. This systemic review details the mechanism and effects of COVID-19 on the GI tract along with the hepatobiliary and pancreatic systems.
Keywords: angiotensin converting enzyme 2; covid-19; gastrointestinal tract; liver; pancreas.
